Combination of two long-acting injectable antipsychotics in treatment-resistant schizophrenia: A retrospective 12-month mirror-image study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of two long-acting injectable antipsychotics in treatment-resistant schizophrenia: A retrospective 12-month mirror-image study

Published:2023-02 Issue: Volume:80 Page:103402
ISSN:1876-2018
Container-title:Asian Journal of Psychiatry
language:en
Short-container-title:Asian Journal of Psychiatry

Author:

Calvin Nathalia,Minischetti Laurence,Salanon Florent,Llorca Pierre-Michel,Pouchon Arnaud,Polosan Mircea,Dondé Clément

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,General Psychology,General Medicine

Reference11 articles.

1. When should you consider combining 2 long-acting injectable antipsychotics?;Diefenderfer;Curr. Psychiatry,2017

2. Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia;Hatta;Asian J. Psychiatr.,2019

3. Treatment-resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group consensus guidelines on diagnosis and terminology;Howes;Am. J. Psychiatry,2017

4. Controversies surrounding the use of long-acting injectable antipsychotic medications for the treatment of patients with Schizophrenia;Kane;CNS Drugs,2021

5. Reasons for discontinuing clozapine: a cohort study of patients commencing treatment;Legge;Schizophr. Res.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review;Brain Sciences;2024-04-26

2. Involuntary administration of long-acting injectable antipsychotics in hospitalized patients with schizophrenia who are incapable of providing informed consent;Asian Journal of Psychiatry;2024-02

3. Patients’ awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychotics;Therapeutic Advances in Psychopharmacology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3